Anti-CD38 therapies such as daratumumab have increased survival time for patients with multiple myeloma. This novel therapy, however, interferes with…
Serology/Genotyping
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy
